title: Mycosis fungoides and Sezary syndrome.
authors.affiliation: Department of Bioimmunotherapy, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
authors.forename: E
authors.initials: E
authors.lastname: Diamandidou
authors.forename: P R
authors.initials: PR
authors.lastname: Cohen
authors.forename: R
authors.initials: R
authors.lastname: Kurzrock
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D016207:Cytokines / Q000032:analysis; D003937:Diagnosis, Differential; D018450:Disease Progression; D005260:Female; D006680:HLA Antigens / Q000032:analysis; D006564:Herpesviridae / Q000472:pathogenicity; D006566:Herpesviridae Infections / Q000150:complications; D015368:Human T-lymphotropic virus 1 / Q000472:pathogenicity; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D015994:Incidence; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D009363:Neoplasm Proteins / Q000032:analysis; D009367:Neoplasm Staging; D009857:Oncogenes; D011701:PUVA Therapy; D011230:Precancerous Conditions / Q000473:pathology; D011379:Prognosis; D012192:Retroviridae Infections / Q000150:complications; D012751:Sezary Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D012871:Skin Diseases / Q000175:diagnosis / Q000473:pathology; D012878:Skin Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D014412:Tumor Virus Infections / Q000150:complications
chemical_list: D016207:Cytokines; D006680:HLA Antigens; D007155:Immunologic Factors; D009363:Neoplasm Proteins; D018799:Intercellular Adhesion Molecule-1